Statistical analysis
alcohol-related liver disease, fibrosis
DISEASE, ALCOHOL-RELATED LIVER DISEASE, FIBROSIS
The sample size was based on a previous study on polyenylphosphatidylcholine in patients with alcohol-related liver disease in which 27% of participants regressed, 57% had stable disease, and 16% had progression by at least one fibrosis stage during a 2-year follow-up.